Scarica l'app Stockscreener
7.399
0.87%
0.064
Dopo l'orario di chiusura:
7.26
-0.139
-1.88%
Precedente Chiudi:
$7.335
Aprire:
$7.2
Volume 24 ore:
6,278
Relative Volume:
0.24
Capitalizzazione di mercato:
$4.31M
Reddito:
$49,300
Utile/perdita netta:
$-6.27M
Rapporto P/E:
-0.814
EPS:
-9.09
Flusso di cassa netto:
$-5.38M
1 W Prestazione:
+1.08%
1M Prestazione:
+1.36%
6M Prestazione:
+508.97%
1 anno Prestazione:
-8.96%
Intervallo 1D:
$7.20
$7.40
Intervallo di 1 settimana:
$7.04
$7.535
Portata 52W:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Confronta ACON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
7.399 | 4.26M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
282.47 | 46.47B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
59.97 | 10.11B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
62.42 | 11.88B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
97.67 | 8.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.59 | 6.56B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Borsa (ACON) Ultime notizie
why aclarion inc. stock attracts strong analyst attentionFree Expert-Led Investment Training - Newser
What makes Aclarion Inc. Equity Warrant stock price move sharplyFree Investment Portfolio Suggestions - Newser
How Aclarion Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
What makes Aclarion Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser
How Aclarion Inc. Equity Warrant stock performs during market volatilityMarket Timing Advice - Newser
Why Aclarion Inc. stock attracts strong analyst attentionFree High-Accuracy Stock Picks - Newser
Why Aclarion Inc. Equity Warrant stock attracts strong analyst attentionTop ROI Selections - Newser
Aclarion (ACON) Stock Price, News & Analysis - MarketBeat
Aclarion, Inc. Adjourns Annual Meeting to Solicit Votes - The Globe and Mail
Healthcare Tech Company Aclarion Extends Stockholder Voting PeriodCritical Meeting Updates - Stock Titan
Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery - Nasdaq
Aclarion (ACON) Showcases NOCISCAN at Spine Surgery Conference | ACON Stock News - GuruFocus
Revolutionary AI-Powered Spine Pain Diagnostic Targets 266M Patient Market at Major Surgery Conference - Stock Titan
Contrasting Aclarion (NASDAQ:ACON) and Aeon Global Health (OTCMKTS:AGHC) - Defense World
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site - Ortho Spine News
Aclarion (ACON) Expands CLARITY Trial with University of Miami H - GuruFocus
Aclarion Inc. Announces UHealth and University of Miami as New Site for CLARITY Clinical Trial Evaluating Nociscan for Chronic Low Back Pain - Nasdaq
Aclarion (NASDAQ:ACON) Upgraded by Wall Street Zen to Hold Rating - Defense World
Aclarion stock price target cut to $20 at Ascendiant Capital - Investing.com Australia
Aclarion stock price target cut to $20 at Ascendiant Capital By Investing.com - Investing.com India
Aclarion, Inc. (NASDAQ:ACON) Sees Large Drop in Short Interest - Defense World
Aclarion (NASDAQ:ACON) Trading Down 1.2% – Here’s Why - Defense World
Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - Ortho Spine News
USC Medical Center Joins Groundbreaking AI Trial to Revolutionize Chronic Back Pain Diagnosis - Stock Titan
Aclarion, Inc. SEC 10-Q Report - TradingView
Aclarion (ACON) Expands CLARITY Trial with Texas Back Institute - GuruFocus
Aclarion Announces Texas Back Institute as New CLARITY Trial Site - Ortho Spine News
Aclarion announces Texas Back Insitute as new CLARITY trial site - TipRanks
Aclarion Inc. Partners with Texas Back Institute for CLARITY Clinical Trial to Enhance Chronic Low Back Pain Treatment - Nasdaq
History Says Now Is the Time to Buy Nvidia Stock - The Globe and Mail
Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News
Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan
Aclarion secures funding for pivotal CLARITY trial - MSN
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News
Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus
Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks
Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq
Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan
Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):